Filing Details

Accession Number:
0001415889-19-000308
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-12 20:50:57
Reporting Period:
2019-03-11
Accepted Time:
2019-03-12 20:50:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1386570 Chromadex Corp. CDXC Medicinal Chemicals & Botanical Products (2833) 262940963
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1437237 Jr L Frank Jaksch 10900 Wilshire Blvd. Suite 650
Los Angeles CA 90024
Executive Chairman Of Board No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-11 33,334 $1.50 234,891 No 4 M Direct
Common Stock Disposition 2019-03-11 14,390 $3.50 220,501 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2019-03-11 33,334 $0.00 33,334 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-05-13 2019-05-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,075,052 Indirect By Black Sheep, FLP
Footnotes
  1. The shares were sold to cover the cost of the exercise of the options which were scheduled to expire on May 13, 2019.
  2. The weighted average sale price for the transaction reported was $3.50, and the range of prices were between $3.47 and $3.53. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.